C. Perou, T. Sorlie, M. Eisen, M. Van-de-rijn, S. Jeffrey et al., Molecular portraits of human breast tumours, Nature, vol.278, issue.6797, pp.747-52, 2000.
DOI : 10.1038/35000501

T. Sorlie, C. Perou, R. Tibshirani, T. Aas, S. Geisler et al., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proceedings of the National Academy of Sciences, vol.179, issue.1, pp.10869-74, 2001.
DOI : 10.1002/(SICI)1096-9896(199605)179:1<31::AID-PATH523>3.0.CO;2-O

URL : http://www.pnas.org/content/98/19/10869.full.pdf

L. Miller, J. Smeds, J. George, V. Vega, L. Vergara et al., From The Cover: An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival, Proceedings of the National Academy of Sciences, vol.21, issue.11, pp.13550-13555, 2005.
DOI : 10.1038/sj.onc.1205250

URL : http://europepmc.org/articles/pmc1197273?pdf=render

T. Miller, J. Balko, Z. Ghazoui, A. Dunbier, H. Anderson et al., A Gene Expression Signature from Human Breast Cancer Cells with Acquired Hormone Independence Identifies MYC as a Mediator of Antiestrogen Resistance, Clinical Cancer Research, vol.17, issue.7, pp.2024-2058, 2011.
DOI : 10.1158/1078-0432.CCR-10-2567

A. Prat and C. Perou, Deconstructing the molecular portraits of breast cancer, Molecular Oncology, vol.9, issue.7-8, pp.5-23, 2011.
DOI : 10.1007/BF02616069

URL : http://onlinelibrary.wiley.com/doi/10.1016/j.molonc.2010.11.003/pdf

P. Jézéquel, D. Loussouarn, C. Guérin-charbonnel, L. Campion, A. Vanier et al., Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response, Breast Cancer Research, vol.9, issue.1, p.43, 2015.
DOI : 10.1371/journal.pone.0095224

G. Thomas and R. Leonard, How Age Affects the Biology of Breast Cancer, Clinical Oncology, vol.21, issue.2, pp.81-86, 2009.
DOI : 10.1016/j.clon.2008.11.006

E. De-kruijf, E. Bastiaannet, F. Rubertá, A. De-craen, P. Kuppen et al., Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients, Molecular Oncology, vol.8, issue.3, pp.1014-1039, 2014.
DOI : 10.1016/S1470-2045(07)70378-9

E. Jenkins, A. Deal, C. Anders, A. Prat, C. Perou et al., Age-Specific Changes in Intrinsic Breast Cancer Subtypes: A Focus on Older Women, The Oncologist, vol.19, issue.10, pp.1076-83, 2014.
DOI : 10.1634/theoncologist.2014-0184

URL : http://theoncologist.alphamedpress.org/content/19/10/1076.full.pdf

C. Sweeney, P. Bernard, R. Factor, M. Kwan, L. Habel et al., Intrinsic Subtypes from PAM50 Gene Expression Assay in a Population-Based Breast Cancer Cohort: Differences by Age, Race, and Tumor Characteristics, Cancer Epidemiology Biomarkers & Prevention, vol.23, issue.5, pp.714-738, 2014.
DOI : 10.1158/1055-9965.EPI-13-1023

URL : http://cebp.aacrjournals.org/content/cebp/23/5/714.full.pdf

R. Edgar, M. Domrachev, and A. Lash, Gene Expression Omnibus: NCBI gene expression and hybridization array data repository, Nucleic Acids Research, vol.30, issue.1, pp.207-217, 2002.
DOI : 10.1093/nar/30.1.207

URL : https://academic.oup.com/nar/article-pdf/30/1/207/9901036/300207.pdf

J. Hubble, J. Demeter, J. H. Mao, M. Nitzberg, M. Reddy et al., Implementation of GenePattern within the Stanford Microarray Database, Nucleic Acids Research, vol.35, issue.suppl_1, pp.898-901, 2009.
DOI : 10.1093/nar/gkl1031

URL : https://academic.oup.com/nar/article-pdf/37/suppl_1/D898/3288645/gkn786.pdf

L. Carey, C. Perou, C. Livasy, L. Dressler, D. Cowan et al., Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study, JAMA, vol.295, issue.21, pp.2492-502, 2006.
DOI : 10.1001/jama.295.21.2492

Y. Su, Y. Zheng, W. Zheng, K. Gu, Z. Chen et al., Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study, BMC Cancer, vol.28, issue.1, p.292, 2011.
DOI : 10.1200/JCO.2009.25.6529

F. Preat, P. Simon, and J. Noel, Differences in breast carcinoma immunohistochemical subtypes between immigrant Arab and European women, Diagnostic Pathology, vol.9, issue.1, p.26, 2014.
DOI : 10.1093/annonc/mdr304

URL : https://diagnosticpathology.biomedcentral.com/track/pdf/10.1186/1746-1596-9-26?site=diagnosticpathology.biomedcentral.com

M. Singh, Y. Ding, L. Zhang, D. Song, Y. Gong et al., Distinct breast cancer subtypes in women with early-onset disease across races, Am J Cancer Res, vol.4, pp.337-52, 2014.

P. Jézéquel, M. Campone, W. Gouraud, C. Guérin-charbonnel, C. Leux et al., bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer, Breast Cancer Research and Treatment, vol.11, issue.Database Issue, pp.765-75, 2012.
DOI : 10.1186/bcr2344

K. Chin, S. Devries, J. Fridlyand, P. Spellman, R. Roydasgupta et al., Genomic and transcriptional aberrations linked to breast cancer pathophysiologies, Cancer Cell, vol.10, issue.6, pp.529-570, 2006.
DOI : 10.1016/j.ccr.2006.10.009

URL : https://doi.org/10.1016/j.ccr.2006.10.009

A. Minn, G. Gupta, P. Siegel, P. Bos, W. Shu et al., Genes that mediate breast cancer metastasis to lung, Nature, vol.31, issue.7050, pp.518-542, 2005.
DOI : 10.1007/s00259-003-1441-5

URL : http://europepmc.org/articles/pmc1283098?pdf=render

A. Ivshina, J. George, O. Senko, B. Mow, T. Putti et al., Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer, Cancer Research, vol.66, issue.21, pp.10292-301, 2006.
DOI : 10.1158/0008-5472.CAN-05-4414

URL : http://cancerres.aacrjournals.org/content/canres/66/21/10292.full.pdf

S. Loi, B. Haibe-kains, C. Desmedt, F. Lallemand, A. Tutt et al., Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor???Positive Breast Carcinomas Through Genomic Grade, Journal of Clinical Oncology, vol.25, issue.10, pp.1239-1285, 2007.
DOI : 10.1200/JCO.2006.07.1522

Y. Zhou, C. Yau, J. Gray, K. Chew, S. Dairkee et al., Enhanced NF??B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer, BMC Cancer, vol.135, issue.Suppl 3, p.59, 2007.
DOI : 10.1158/1078-0432.CCR-05-2296

URL : https://bmccancer.biomedcentral.com/track/pdf/10.1186/1471-2407-7-59?site=bmccancer.biomedcentral.com

C. Desmedt, F. Piette, S. Loi, Y. Wang, F. Lallemand et al., Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series, Clinical Cancer Research, vol.13, issue.11, pp.3207-3221, 2007.
DOI : 10.1158/1078-0432.CCR-06-2765

C. Anders, C. Acharya, D. Hsu, G. Broadwater, K. Garman et al., Age-specific differences in oncogenic pathway deregulation seen in human breast tmors, PLoS One, vol.2, 1373.
DOI : 10.1371/journal.pone.0001373

URL : https://doi.org/10.1371/journal.pone.0001373

S. Loi, B. Haibe-kains, C. Desmedt, P. Wirapati, F. Lallemand et al., Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen, BMC Genomics, vol.9, issue.1, p.239, 2008.
DOI : 10.1186/1471-2164-9-239

URL : https://bmcgenomics.biomedcentral.com/track/pdf/10.1186/1471-2164-9-239?site=bmcgenomics.biomedcentral.com

C. Desmedt, A. Giobbie-hurder, P. Neven, R. Paridaens, M. Christiaens et al., The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1???98 trial, BMC Medical Genomics, vol.4, issue.1, p.40, 2009.
DOI : 10.1016/j.jsbmb.2006.09.012

F. Sircoulomb, I. Bekhouche, P. Finetti, J. Adélaïde, B. Hamida et al., Genome profiling of ERBB2-amplified breast cancers, BMC Cancer, vol.61, issue.1, p.539, 2010.
DOI : 10.1136/jcp.2007.052431

URL : https://bmccancer.biomedcentral.com/track/pdf/10.1186/1471-2407-10-539?site=bmccancer.biomedcentral.com

Y. Li, L. Zou, Q. Li, B. Haibe-kains, R. Tian et al., Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer, Nature Medicine, vol.9, issue.2, pp.214-222, 2010.
DOI : 10.1016/S0140-6736(05)17947-1

URL : http://europepmc.org/articles/pmc2826790?pdf=render

K. Kao, K. Chang, H. Hsu, and A. Huang, Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization, BMC Cancer, vol.335, issue.1, p.143, 2011.
DOI : 10.1056/NEJM199610033351408

URL : https://bmccancer.biomedcentral.com/track/pdf/10.1186/1471-2407-11-143?site=bmccancer.biomedcentral.com

R. Sabatier, P. Finetti, N. Cervera, E. Lambaudie, B. Esterni et al., A gene expression signature identifies two prognostic subgroups of basal breast cancer, Breast Cancer Research and Treatment, vol.280, issue.3, pp.407-427, 2011.
DOI : 10.1074/jbc.M504249200

URL : https://hal.archives-ouvertes.fr/hal-00583558

C. Hatzis, L. Pusztai, V. Valero, D. Booser, L. Esserman et al., A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer, JAMA, vol.305, issue.18, pp.1873-81, 2011.
DOI : 10.1001/jama.2011.593

URL : http://jama.jamanetwork.com/data/journals/jama/20328/joc15042_1873_1881.pdf

S. Nagalla, J. Chou, M. Willingham, J. Ruiz, J. Vaughn et al., Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis, Genome Biology, vol.14, issue.4, p.34, 2013.
DOI : 10.1158/1078-0432.CCR-06-2765

URL : https://genomebiology.biomedcentral.com/track/pdf/10.1186/gb-2013-14-4-r34?site=genomebiology.biomedcentral.com

S. Diab, R. Elledge, and G. Clark, Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer, Journal of the National Cancer Institute, vol.92, issue.7, pp.550-556, 2000.
DOI : 10.1093/jnci/92.7.550

L. Dunnwald, M. Rossing, and C. Li, Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients, Breast Cancer Research, vol.295, issue.4 Pt 2, p.6, 2007.
DOI : 10.1001/jama.295.14.1658

URL : http://doi.org/10.1186/bcr1639

H. Wildiers, V. Calster, B. Van-de-poll-franse, L. Hendrickx, W. Røislien et al., Relationship Between Age and Axillary Lymph Node Involvement in Women With Breast Cancer, Journal of Clinical Oncology, vol.27, issue.18, pp.2931-2938, 2009.
DOI : 10.1200/JCO.2008.16.7619

M. Schonberg, E. Marcantonio, D. Li, R. Silliman, L. Ngo et al., Breast Cancer Among the Oldest Old: Tumor Characteristics, Treatment Choices, and Survival, Journal of Clinical Oncology, vol.28, issue.12, pp.2038-2083, 2010.
DOI : 10.1200/JCO.2009.25.9796

URL : http://europepmc.org/articles/pmc2860406?pdf=render

N. Honma, G. Sakamoto, F. Akiyama, Y. Esaki, M. Sawabe et al., Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor status, Histopathology, vol.56, issue.2, pp.120-127, 2003.
DOI : 10.1002/ijc.2910520415

S. Agoff, P. Swanson, H. Linden, S. Hawes, and T. Lawton, Androgen Receptor Expression in Estrogen Receptor???Negative Breast Cancer, American Journal of Clinical Pathology, vol.120, issue.5, pp.725-756, 2003.
DOI : 10.1309/42F00D0DJD0J5EDT

URL : https://academic.oup.com/ajcp/article-pdf/120/5/725/4986507/ajcpath120-0725.pdf

J. Cao, S. Gollapudi, E. Sharman, Z. Jia, and S. Gupta, T cells, Aging Cell, vol.288, issue.1, pp.19-31, 2010.
DOI : 10.1042/BJ20082234

L. Harries, D. Hernandez, W. Henley, A. Wood, A. Holly et al., Human aging is characterized by focused changes in gene expression and deregulation of alternative splicing, Aging Cell, vol.5, issue.5, pp.868-78, 2011.
DOI : 10.1371/journal.pone.0010693

N. Todorovic-rkovic and J. Milovanovic, Interleukin-8 in Breast Cancer Progression, Journal of Interferon & Cytokine Research, vol.33, issue.10, pp.563-70, 2013.
DOI : 10.1089/jir.2013.0023

J. Singh, B. Simoes, S. Howell, G. Farnie, and R. Clarke, Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells, Breast Cancer Research, vol.72, issue.24 Suppl, p.210, 2013.
DOI : 10.1158/1078-0432.CCR-12-3450

URL : https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3436?site=breast-cancer-research.biomedcentral.com

G. Honeth, P. Bendahl, M. Ringnér, L. Saal, S. Gruvberger-saal et al., The CD44+/CD24-phenotype is enriched in basal-like breast tumors, Breast Cancer Research, vol.122, issue.3, p.53, 2008.
DOI : 10.1002/ijc.23103

URL : https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2108?site=breast-cancer-research.biomedcentral.com

P. Farmer, H. Bonnefoi, P. Anderle, D. Cameron, P. Wirapati et al., A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer, Nature Medicine, vol.57, issue.1, pp.68-74, 2009.
DOI : 10.1186/bcr1608

C. Desmedt, B. Haibe-kains, P. Wirapati, M. Buyse, D. Larsimont et al., Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes, Clinical Cancer Research, vol.14, issue.16, pp.5158-65, 2008.
DOI : 10.1158/1078-0432.CCR-07-4756

URL : http://clincancerres.aacrjournals.org/content/clincanres/14/16/5158.full.pdf

P. Wirapati, C. Sotiriou, S. Kunkel, P. Farmer, S. Pradervand et al.,

, Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures, Breast Cancer Res, vol.10, p.65, 2008.

V. Tusher, R. Tibshirani, and G. Chu, Significance analysis of microarrays applied to the ionizing radiation response, Proceedings of the National Academy of Sciences, vol.57, issue.2, pp.5116-5137, 2001.
DOI : 10.2307/3579583

M. Ashburner, C. Ball, J. Blake, D. Botstein, H. Butler et al., Gene Ontology: tool for the unification of biology, Nature Genetics, vol.9, issue.1, pp.25-34, 2000.
DOI : 10.1091/mbc.9.12.3273

J. Chen, E. Bardes, B. Aronow, and A. Jegga, ToppGene Suite for gene list enrichment analysis and candidate gene prioritization, Nucleic Acids Research, vol.18, issue.8, pp.305-316, 2009.
DOI : 10.1093/hmg/ddp041

P. Farmer, H. Bonnefoi, V. Becette, M. Tubiana-hulin, P. Fumoleau et al., Identification of molecular apocrine breast tumours by microarray analysis, Oncogene, vol.24, issue.29, pp.4660-71, 2005.
DOI : 10.1073/pnas.201162998

A. Doane, M. Danso, P. Lal, M. Donaton, L. Zhang et al., An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen, Oncogene, vol.25, issue.28, pp.3994-4008, 2006.
DOI : 10.1038/sj.onc.1209415

H. Muss, S. Woolf, D. Berry, C. Cirrincione, R. Weiss et al., Adjuvant Chemotherapy in Older and Younger Women With Lymph Node???Positive Breast Cancer, JAMA, vol.293, issue.9, pp.1073-81, 2005.
DOI : 10.1001/jama.293.9.1073

L. Biganzoli, H. Wildiers, C. Oakman, L. Marotti, S. Loibl et al., Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA), The Lancet Oncology, vol.13, issue.4, pp.148-160, 2012.
DOI : 10.1016/S1470-2045(11)70383-7

N. Rocco, C. Rispoli, G. Pagano, S. Ascione, R. Compagna et al., Undertreatment of breast cancer in the elderly, BMC Surgery, vol.13, issue.Suppl 2, p.26, 2013.
DOI : 10.1007/s00520-010-0883-0

W. Satariano and D. Ragland, The Effect of Comorbidity on 3-Year Survival of Women with Primary Breast Cancer, Annals of Internal Medicine, vol.120, issue.2, pp.104-114, 1994.
DOI : 10.7326/0003-4819-120-2-199401150-00002

D. Morrison, D. Rahardja, E. King, Y. Peng, and V. Sarode, Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer, British Journal of Cancer, vol.16, issue.2, pp.382-389, 2012.
DOI : 10.1016/S1470-2045(09)70262-1

URL : http://www.nature.com/bjc/journal/v107/n2/pdf/bjc2012219a.pdf

G. Finak, N. Bertos, F. Pepin, S. Sadekova, M. Souleimanova et al., Stromal gene expression predicts clinical outcome in breast cancer, Nature Medicine, vol.25, issue.5, pp.518-545, 2008.
DOI : 10.4049/jimmunol.170.6.3369

R. Salgado, C. Denkert, S. Demaria, N. Sirtaine, F. Klauschen et al., The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014, Annals of Oncology, vol.32, issue.6030, pp.259-71, 2015.
DOI : 10.1126/science.1198704

C. Hagerling, A. Casbon, and Z. Werb, Balancing the innate immune system in tumor development, Trends in Cell Biology, vol.25, issue.4, pp.214-234, 2015.
DOI : 10.1016/j.tcb.2014.11.001

URL : http://europepmc.org/articles/pmc4380818?pdf=render

G. Dunn, L. Old, and R. Schreiber, The Three Es of Cancer Immunoediting, Annual Review of Immunology, vol.22, issue.1, pp.329-60, 2004.
DOI : 10.1146/annurev.immunol.22.012703.104803

URL : http://file.yynet.cn:8080/27feca87400d1a0660babc7d1ff0d60b/the+three+ES+of+cancer+immunoediting.pdf

K. Liu, S. Caldwell, and S. Abrams, Immune Selection and Emergence of Aggressive Tumor Variants as Negative Consequences of Fas-Mediated Cytotoxicity and Altered IFN-??-Regulated Gene Expression, Cancer Research, vol.65, issue.10, pp.4376-88, 2005.
DOI : 10.1158/0008-5472.CAN-04-4269

URL : http://cancerres.aacrjournals.org/content/canres/65/10/4376.full.pdf